-
The hearing of the US Senate version of the Biosafety Act is about to be held
On the morning of March 6th, local time, at a hearing held by the Homeland Security and Government Affairs Committee of the United States Senate, the Senate version of the Biosafety Act (No. S.3558) ... -
Baekje Shenzhou PD-1 has been approved by FDA as the second product in China after Junshi Biotechnology
Beijing, March 15th (Reporter Cao Qian, Intern Xie Xiaoxuan) Today, BeiGene announced that its PD-1 inhibitor, Tevimbra, has been approved by the FDA for the treatment of advanced or metastatic esoph ... -
Has the top student in the domestic CAR-T field received a merger offer? Legendary creature claims not to comment on rumors
On July 12th, it was reported that Legendary Biology had received a merger offer; After the news came out, the stock price of Legendary Biology fluctuated. On July 17th, Legendary Biology replied to ...